About: OKYO Pharma Limited, a clinical-stage ophthalmology company, develops therapies for corneal and anterior diseases in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase 2 clinical trials for the treatment of dry eye disease and neuropathic corneal pain. The company is also developing OK-201 for the treatment of acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.46 (+1.37%)
OKYO NASDAQ OKYO Pharma Limited
OKYO Pharma Limited share price
OKYO price activity
Last Price
$1.460
Change (24hr)
0.02 USD (1.37%)
Volume
15.20K
Volume (4w avg)
-
Open
$1.46
Day Range
$1.41 - $1.47
Previous Close
$1.44
Last Trade
13 Oct, 3:15 pm GMT+0
Delayed
13 Oct, 3:15 pm GMT+0
OKYO price performance
Delayed
13 Oct, 3:15 pm GMT+0
OKYO Market Signals